Login to Your Account


New drugs, spin on old ones aim for piece of ADHD market

By Brian Orelli
Contributing Writer

Monday, July 14, 2014

The attention deficit hyperactivity disorder (ADHD) market is $10 billion strong, but grabbing a piece of the pie with so many drugs already on the market, including some generics, requires differentiation.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription